Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
…, Q Zhu, M Hu, XY Li, P Peng, HZShi- European …, 2020 - Eur Respiratory Soc
The aim of this study was to identify factors associated with the death of patients with COVID-19
pneumonia caused by the novel coronavirus SARS-CoV-2. All clinical and laboratory …
pneumonia caused by the novel coronavirus SARS-CoV-2. All clinical and laboratory …
Comparison of hospitalized patients with ARDS caused by COVID-19 and H1N1
…, XY Li, Y Li, LR Liang, ZH Tong, B Sun, P Peng, HZShi- Chest, 2020 - Elsevier
Background Since the outbreak of coronavirus disease 2019 (COVID-19) in China in
December 2019, considerable attention has been focused on its elucidation. However, it is also …
December 2019, considerable attention has been focused on its elucidation. However, it is also …
[HTML][HTML]Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis
QL Liang, HZShi, K Wang, SM Qin, XJ Qin - Respiratory medicine, 2008 - Elsevier
Background Conventional tests are not always helpful in making a diagnosis of tuberculous
pleurisy. Many studies have investigated the usefulness of adenosine deaminase (ADA) in …
pleurisy. Many studies have investigated the usefulness of adenosine deaminase (ADA) in …
Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in Wuhan, China
…, YL Li, Y Hu, XY Li, B Sun, P Peng, HZShi- Annals of the …, 2020 - atsjournals.org
Rationale: The current outbreak of coronavirus disease (COVID-19) pneumonia caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, spreads …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, spreads …
[HTML][HTML]Lymph node trafficking and antigen presentation by endobronchial eosinophils
HZShi, A Humbles, C Gerard, Z Jin… - The Journal of clinical …, 2000 - Am Soc Clin Investig
因为嗜酸性粒细胞recruited into the airways in allergic diseases are exposed to inhaled
allergens, we evaluated whether eosinophils within the endobronchial lumen can function in …
allergens, we evaluated whether eosinophils within the endobronchial lumen can function in …
Diagnostic value of interferon-γ in tuberculous pleurisy: a metaanalysis
J Jiang, HZShi, QL Liang, SM Qin, XJ Qin - Chest, 2007 - Elsevier
Background Conventional tests are not always helpful in making a diagnosis of tuberculous
pleurisy. Many studies have investigated the usefulness of interferon (IFN)-γ measurements …
pleurisy. Many studies have investigated the usefulness of interferon (IFN)-γ measurements …
Eosinophils function as antigen‐presenting cells
HZShi- Journal of leukocyte biology, 2004 - Wiley Online Library
Eosinophils release lipid mediators, including leukotriene C 4 , platelet‐activating factor, and
liposins, and contain four distinct granule cationic proteins, major basic protein, eosinophil …
liposins, and contain four distinct granule cationic proteins, major basic protein, eosinophil …
[HTML][HTML]A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2
…, WL Ma, BH Yang, NC Jiang, ZC Gao, HZShi… - Journal of Microbiology …, 2021 - Elsevier
Background The current outbreak of coronavirus disease 2019 (COVID-19) caused by
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, Hubei, China, …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, Hubei, China, …
Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
HZShi, CQ XIAO, D ZHONG, SM QIN, YI Liu… - American journal of …, 1998 - atsjournals.org
In order to investigate the role of interleukin-5 (IL-5) in airway hyperreactivity and eosinophilia,
we observed the effect of inhaled recombinant human IL-5 on airway responsiveness to …
we observed the effect of inhaled recombinant human IL-5 on airway responsiveness to …
Early use of corticosteroid may prolong SARS-CoV-2 shedding in non-intensive care unit patients with COVID-19 pneumonia: a multicenter, single-blind, randomized …
…, Y Zhao, J Xie, Z Ding, XL He, W Wang, RH Jin, HZShi… - Respiration, 2021 - karger.com
Background: There is still no clinical evidence available to support or to oppose corticosteroid
treatment for coronavirus disease 2019 (COVID-19) pneumonia. Objective: To investigate …
treatment for coronavirus disease 2019 (COVID-19) pneumonia. Objective: To investigate …